Ana De Jesus‐Acosta

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Aurélien Marabelle, Dung T. Le, Paolo A. Ascierto et al. · Journal of Clinical Oncology · 2019 · 2.8K citations · Full text

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Berna C. Özdemir, Tsvetelina Pentcheva‐Hoang, Julienne L. Carstens et al. · Cancer Cell · 2014 · 2.5K citations

Pancreatic Cancer, Medicine, Accelerates Pancreas Cancer +8

Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer

Thomas B. Karasic, Mark H. O’Hara, Arturo Loaiza‐Bonilla et al. · JAMA Oncology · 2019 · 277 citations · Full text

Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable Survival

Ludmila Danilova, Won Jin Ho, Qingfeng Zhu et al. · Cancer Immunology Research · 2019 · 258 citations · Full text

Personalizing Cancer Treatment in the Age of Global Genomic Analyses: <i>PALB2</i> Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer

Maria Cristina Villarroel, N.V. Rajeshkumar, Ignacio Garrido‐Laguna et al. · Molecular Cancer Therapeutics · 2010 · 245 citations · Full text